IRONWOOD PHARMACEUTICALS, INC. Notes Payable, Noncurrent
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Notes Payable, Noncurrent of $78.33 million as of 2019-06-30, per its 10-Q filed 2019-07-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2020-02-13
- 2019-06-30: Notes Payable, Noncurrent $78.33M.
- 2019-03-31: Notes Payable, Noncurrent $90.14M.
- 2018-12-31: Notes Payable, Noncurrent $100.54M.
- 2018-09-30: Notes Payable, Noncurrent $108.59M.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2019-06-30 | $78.33M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $90.14M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $100.54M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $108.59M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $122.61M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $135.22M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $146.90M 10-K · filed 2019-02-25 | |
| 2016-12-31 | $132.25M 10-K · filed 2017-02-22 | |
| 2016-09-30 | $131.94M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $111.94M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $124.67M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $132.96M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $141.78M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $147.79M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $158.16M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $158.15M 10-K · filed 2016-02-19 | $162.34M 10-K · filed 2015-02-18 |
| 2014-09-30 | $165.39M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $168.14M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $170.31M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $174.67M 10-K · filed 2015-02-18 | |
| 2013-09-30 | $174.65M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $174.63M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $174.60M 10-Q · filed 2013-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |